Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Gynecol Oncol. 2012 Dec 12;128(3):493–499. doi: 10.1016/j.ygyno.2012.12.007

Figure 2.

Figure 2

53BP1 protein expression by genetic status. Primary and recurrent BRCA1-mutated carcinomas had significantly higher 53BP1 protein expression compared to wildtype carcinomas. BRCA2-mutated carcinomas had a trend toward higher 53BP1 expression compared to wildtype carcinomas in primary but not recurrent carcinomas. There was no significant difference between primary and recurrent carcinomas for any genetic subgroup.